Found: 22
Select item for more details and to access through your institution.
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
- Published in:
- Allergy, 2020, v. 75, n. 11, p. 2879, doi. 10.1111/all.14416
- By:
- Publication type:
- Article
Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 845, doi. 10.1111/hae.13558
- By:
- Publication type:
- Article
Immune tolerance induction: What have we learned over time?
- Published in:
- Haemophilia, 2018, v. 24, p. 3, doi. 10.1111/hae.13445
- By:
- Publication type:
- Article
Immune tolerance induction: What have we learned over time?
- Published in:
- Haemophilia, 2018, v. 24, p. 3, doi. 10.1111/hae.13445
- By:
- Publication type:
- Article
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.
- Published in:
- Haemophilia, 2017, v. 23, p. e170, doi. 10.1111/hae.13215
- By:
- Publication type:
- Article
Achievements, challenges and unmet needs for haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2016, v. 22, p. 1, doi. 10.1111/hae.12860
- By:
- Publication type:
- Article
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. 87, doi. 10.1111/hae.12774
- By:
- Publication type:
- Article
Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors.
- Published in:
- Haemophilia, 2015, v. 21, n. 3, p. 358, doi. 10.1111/hae.12602
- By:
- Publication type:
- Article
Spotlight on the human factor: building a foundation for the future of haemophilia A management.
- Published in:
- Haemophilia, 2015, v. 21, p. 1, doi. 10.1111/hae.12582
- By:
- Publication type:
- Article
A review of immune tolerance induction with Haemate<sup>®</sup> P in haemophilia A.
- Published in:
- Haemophilia, 2014, v. 20, n. 3, p. 333, doi. 10.1111/hae.12288
- By:
- Publication type:
- Article
The immune tolerance induction ( ITI) dose debate: does the International ITI Study provide a clearer picture?
- Published in:
- Haemophilia, 2013, v. 19, p. 12, doi. 10.1111/hae.12051
- By:
- Publication type:
- Article
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH<sup>®</sup>) in 14 patients with severe haemophilia A.
- Published in:
- Haemophilia, 2011, v. 17, n. 5, p. e837, doi. 10.1111/j.1365-2516.2011.02577.x
- By:
- Publication type:
- Article
Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series.
- Published in:
- Haemophilia, 2010, v. 16, n. 1, p. 90, doi. 10.1111/j.1365-2516.2009.02116.x
- By:
- Publication type:
- Article
The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report.
- Published in:
- 2009
- By:
- Publication type:
- Report
Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development.
- Published in:
- Haemophilia, 2006, v. 12, p. 102, doi. 10.1111/j.1365-2516.2006.01373.x
- By:
- Publication type:
- Article
Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development.
- Published in:
- Haemophilia, 2006, v. 12, p. 102, doi. 10.1111/j.1365-2516.2006.01373.x
- By:
- Publication type:
- Article
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 10, p. 1391, doi. 10.1111/cea.13974
- By:
- Publication type:
- Article
Epidemiology of Inhibitors in Haemophilia A.
- Published in:
- Vox Sanguinis, 1996, v. 70, p. 2, doi. 10.1111/j.1423-0410.1996.tb01341.x
- By:
- Publication type:
- Article
Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding - Successful thrombolysis under heparin therapy.
- Published in:
- European Journal of Pediatrics, 1999, v. 158, n. 15, p. S180, doi. 10.1007/PL00014351
- By:
- Publication type:
- Article
Abstracts.
- Published in:
- 1999
- By:
- Publication type:
- Abstract
Prevention of joint damage in hemophilic children with early prophylaxis.
- Published in:
- Der Orthopäde, 1999, v. 28, n. 4, p. 341, doi. 10.1007/PL00003616
- By:
- Publication type:
- Article
When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
- Published in:
- Haemophilia, 1998, v. 4, n. 4, p. 413
- By:
- Publication type:
- Article